These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37191190)

  • 1. Gut dysbiosis-derived low-grade endotoxemia: A common basis for liver and cardiovascular disease.
    Violi F; Nocella C; Bartimoccia S; Castellani V; Carnevale R; Pignatelli P; Cammisotto V
    Kardiol Pol; 2023; 81(6):563-571. PubMed ID: 37191190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium?
    Violi F; Castellani V; Menichelli D; Pignatelli P; Pastori D
    Am Heart J; 2023 Oct; 264():40-48. PubMed ID: 37301317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxemia and Platelets: 2 Players of Intrahepatic Microthrombosis in NAFLD.
    Violi F; Pastori D; Pignatelli P; Cammisotto V
    JACC Basic Transl Sci; 2024 Mar; 9(3):404-413. PubMed ID: 38559621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease.
    Violi F; Cammisotto V; Bartimoccia S; Pignatelli P; Carnevale R; Nocella C
    Nat Rev Cardiol; 2023 Jan; 20(1):24-37. PubMed ID: 35840742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia.
    Xue L; He J; Gao N; Lu X; Li M; Wu X; Liu Z; Jin Y; Liu J; Xu J; Geng Y
    Sci Rep; 2017 Mar; 7():45176. PubMed ID: 28349964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis.
    Violi F; Pignatelli P; Castellani V; Carnevale R; Cammisotto V
    Blood Rev; 2023 Jan; 57():100998. PubMed ID: 35985881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut dysbiosis induces the development of mastitis through a reduction in host anti-inflammatory enzyme activity by endotoxemia.
    Zhao C; Hu X; Bao L; Wu K; Zhao Y; Xiang K; Li S; Wang Y; Qiu M; Feng L; Meng X; Zhang N; Fu Y
    Microbiome; 2022 Dec; 10(1):205. PubMed ID: 36451232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
    Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
    World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction.
    Carnevale R; Sciarretta S; Valenti V; di Nonno F; Calvieri C; Nocella C; Frati G; Forte M; d'Amati G; Pignataro MG; Severino A; Cangemi R; Arrivi A; Dominici M; Mangieri E; Gaudio C; Tanzilli G; Violi F
    Eur Heart J; 2020 Sep; 41(33):3156-3165. PubMed ID: 31898723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Host Reaction in Liver Diseases.
    Fukui H
    Microorganisms; 2015 Oct; 3(4):759-91. PubMed ID: 27682116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis.
    Nishimura N; Kaji K; Kitagawa K; Sawada Y; Furukawa M; Ozutsumi T; Fujinaga Y; Tsuji Y; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Fukui H; Yoshiji H
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203178
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Panpetch W; Sawaswong V; Chanchaem P; Ondee T; Dang CP; Payungporn S; Leelahavanichkul A
    Front Immunol; 2020; 11():561652. PubMed ID: 33101279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides-TLR4 Axis Downregulation.
    Schirone L; Overi D; Carpino G; Carnevale R; De Falco E; Nocella C; D'Amico A; Bartimoccia S; Cammisotto V; Castellani V; Frati G; Sciarretta S; Gaudio E; Pignatelli P; Alvaro D; Violi F
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics.
    Moludi J; Maleki V; Jafari-Vayghyan H; Vaghef-Mehrabany E; Alizadeh M
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):927-939. PubMed ID: 31894861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Bacteremia in Dextran Sulfate-Induced Colitis in Splenectomy Mice Correlates with Gut Dysbiosis and LPS Tolerance.
    Thim-Uam A; Makjaroen J; Issara-Amphorn J; Saisorn W; Wannigama DL; Chancharoenthana W; Leelahavanichkul A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions.
    Mohammad S; Thiemermann C
    Front Immunol; 2020; 11():594150. PubMed ID: 33505393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
    Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
    World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?
    Villard A; Boursier J; Andriantsitohaina R
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G485-G495. PubMed ID: 33471632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases.
    An L; Wirth U; Koch D; Schirren M; Drefs M; Koliogiannis D; Nieß H; Andrassy J; Guba M; Bazhin AV; Werner J; Kühn F
    J Gastrointest Surg; 2022 Mar; 26(3):671-683. PubMed ID: 34734369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update.
    Fukui H
    Gut Liver; 2021 Sep; 15(5):666-676. PubMed ID: 33071239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.